Nederman (NMAN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
17 Apr, 2026Executive summary
Maintained resilience and high activity across all divisions despite a volatile market, though orders and revenue declined year-over-year.
Strengthened position in structurally growing industries such as food, pharma, life sciences, wind power, hydrogen, batteries, and recycling, but this led to lower sales and EBIT margins.
Continued investments in operational efficiency, automation, and digitalization supported performance.
Activity picked up at the end of Q1 and continued into April, with cautious optimism for future demand.
Cash flow from operations was negative, mainly due to working capital build-up, which is typical for Q1.
Financial highlights
Orders received were SEK 1,267m, down from just over SEK 1,500m in Q1 last year; 6.7% down currency neutral, 9.2% organic decline.
Sales were SEK 1,257m, down 2% currency neutral and 5.5% organically; currency impact was -9%.
Adjusted EBITDA was SEK 117m (margin 9.3%) versus SEK 143m (margin 10.1%) last year; SEK 12m of EBITDA drop due to currency effects.
Earnings per share SEK 1.31, down from SEK 1.69 in Q1 last year.
Cash flow from operations was negative at SEK -19.9m, with capital expenditure at SEK 37.2m.
Outlook and guidance
Demand remains subdued in many sectors, but strong service and digital segments support performance.
Activity improved late in Q1; if sustained, could benefit future quarters.
Considerable uncertainty persists, making broader demand recovery difficult to forecast.
Well-positioned to improve profitability when demand recovers, supported by a strong balance sheet and ongoing investments in efficiency.
Latest events from Nederman
- Currency-neutral growth and strong cash flow, but margins pressured by external factors.NMAN
Q4 202527 Feb 2026 - Strong margins and stable cash flow achieved despite lower sales and orders, with a positive outlook.NMAN
Q2 20243 Feb 2026 - Strong order intake, solid margins, and Duroair acquisition support a positive outlook.NMAN
Q3 202419 Jan 2026 - Stable sales, lower profit, and strong order growth in most divisions despite market volatility.NMAN
Q1 202525 Dec 2025 - Record profit, strong cash flow, and strategic growth amid ongoing macro uncertainty.NMAN
Q4 202423 Dec 2025 - Currency-neutral growth led by Extraction & Filtration, but margins and profit declined.NMAN
Q2 202516 Nov 2025 - Profitability and sales rose in Q3 2025, but orders declined amid market headwinds.NMAN
Q3 202523 Oct 2025